Literature DB >> 22171125

Hepatitis B virus infection and the risk of hepatocellular carcinoma.

Ya-Jun Tan1.   

Abstract

Epidemiological studies have provided overwhelming evidence for a causal role of chronic hepatitis B virus (HBV) infection in the development of hepatocellular carcinoma (HCC). However, the pathogenesis of HBV infection and carcinogenesis of HBV-associated HCC are still elusive. This review will summarize the current knowledge on the mechanisms involved in HBV-related liver carcinogenesis. The role of HBV in tumor formation appears to be complex, and may involve both direct and indirect mechanisms. Integration of HBV DNA into the host genome occurs at early steps of clonal tumor expansion, and it has been shown to enhance the host chromosomal instability, leading to large inverted duplications, deletions and chromosomal translocations. It has been shown that the rate of chromosomal alterations is increased significantly in HBV-related tumors. Prolonged expression of the viral regulatory HBV x protein may contribute to regulating cellular transcription, protein degradation, proliferation, and apoptotic signaling pathways, and it plays a critical role in the development of hepatocellular carcinoma.

Entities:  

Keywords:  Hepatitis B virus genotypic variations; Hepatitis B virus infection; Hepatitis B virus x protein; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2011        PMID: 22171125      PMCID: PMC3235627          DOI: 10.3748/wjg.v17.i44.4853

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression.

Authors:  Tzu-Ching Kuo; Chuck C-K Chao
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

2.  A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.

Authors:  Qingming Dong; Henry L Y Chan; Zheng Liu; Denise P C Chan; Bao Zhang; Yangchao Chen; Hsiang-Fu Kung; Joseph J Y Sung; Ming-Liang He
Journal:  Biochem Biophys Res Commun       Date:  2008-08-08       Impact factor: 3.575

3.  Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

Authors:  Hang Su; Jing Zhao; Yujuan Xiong; Teng Xu; Fan Zhou; Yunfei Yuan; Ying Zhang; Shi-Mei Zhuang
Journal:  Mutat Res       Date:  2008-02-14       Impact factor: 2.433

4.  HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Lian-Ying Ge; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Xue-Yan Wang; Tim J Harrison
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

5.  Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization.

Authors:  Petr Novak; Taylor J Jensen; James C Garbe; Martha R Stampfer; Bernard W Futscher
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

Review 6.  Hepatitis B virus-cell interactions and pathogenesis.

Authors:  David H Nguyen; Laurie Ludgate; Jianming Hu
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

7.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

Authors:  Taro Yamashita; Junfang Ji; Anuradha Budhu; Marshonna Forgues; Wen Yang; Hong-Yang Wang; Huliang Jia; Qinghai Ye; Lun-Xiu Qin; Elaine Wauthier; Lola M Reid; Hiroshi Minato; Masao Honda; Shuichi Kaneko; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2008-12-06       Impact factor: 22.682

8.  Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.

Authors:  Jian-Min Yuan; Alex Ambinder; Yunhua Fan; Yu-Tang Gao; Mimi C Yu; John D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

9.  Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Jian Huang; Xue-Yan Wang; Tim J Harrison
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

10.  Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Shiou-Hwei Yeh; Pei-Jer Chen; Uchenna H Iloeje; Chin-Lan Jen; Jun Su; Li-Yu Wang; Sheng-Nan Lu; San-Lin You; Ding-Shinn Chen; Yun-Fan Liaw; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

View more
  36 in total

1.  Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.

Authors:  Hiroshi Matsumura; Kazushige Nirei; Hitomi Nakamura; Teruhisa Higuchi; Yasuo Arakawa; Masahiro Ogawa; Naohide Tanaka; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

2.  Occult Hepatitis B Infection in Recent Immigrants to Italy: Occult B Infection in Immigrants.

Authors:  Gaetano Scotto; Vincenzina Fazio; Coppola Nicola
Journal:  J Community Health       Date:  2020-04

3.  Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.

Authors:  Anil Arora; Praveen Sharma; Pankaj Tyagi; Vikas Singla; Veronica Arora; Naresh Bansal; Jay Toshniwal; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2013-09-20

4.  Prevalence of Hepatitis B and Hepatitis C Among School Children of Urban and Rural Jaipur, Rajasthan.

Authors:  Kapil Dhingra; Sandeep Ratra; Amit Tanwar; Munesh Kumar; Mukesh Jain; Gaurav Gupta; Shivi Nijhawan; Hemendra Bharadwaj; Manisha Nijhawn; Sandeep Nijhawan
Journal:  J Clin Exp Hepatol       Date:  2019-11-26

5.  Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.

Authors:  Scott Bowden; Stephen Locarnini; Ting-Tsung Chang; You-Chen Chao; Kwang-Hyub Han; Robert G Gish; Robert A de Man; Miao Yu; Cyril Llamoso; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 6.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

7.  Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure.

Authors:  Yihui Rong; Haihan Song; Shaoli You; Bing Zhu; Hong Zang; Yi Zhao; Yongli Li; Zhihong Wan; Hongling Liu; Aimin Zhang; Long Xiao; Shaojie Xin
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 8.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort study.

Authors:  Lei Li; Wei Liu; Yu-Han Chen; Chun-Lei Fan; Pei-Ling Dong; Fei-Li Wei; Bing Li; De-Xi Chen; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

10.  Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yan Du; Xue Han; Rui Pu; Jiaxin Xie; Yuwei Zhang; Guangwen Cao
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.